
<!DOCTYPE html>
<html lang="zh-TW">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>腎臟學研究週報 - 2026年02月09日</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            line-height: 1.6;
            color: #333;
            max-width: 800px;
            margin: 0 auto;
            padding: 20px;
            background-color: #f5f5f5;
        }
        .container {
            background-color: #ffffff;
            border-radius: 10px;
            padding: 30px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }
        .header {
            text-align: center;
            border-bottom: 3px solid #1E3A5F;
            padding-bottom: 20px;
            margin-bottom: 30px;
        }
        .header h1 {
            color: #1E3A5F;
            margin: 0;
            font-size: 28px;
        }
        .header p {
            color: #666;
            margin: 10px 0 0 0;
        }
        .metrics {
            display: flex;
            justify-content: space-around;
            flex-wrap: wrap;
            margin: 20px 0;
            padding: 20px;
            background-color: #f8f9fa;
            border-radius: 8px;
        }
        .metric {
            text-align: center;
            padding: 10px 20px;
        }
        .metric-value {
            font-size: 36px;
            font-weight: bold;
            color: #1E3A5F;
        }
        .metric-label {
            font-size: 14px;
            color: #666;
        }
        .section {
            margin: 30px 0;
        }
        .section h2 {
            color: #1E3A5F;
            border-left: 4px solid #1E3A5F;
            padding-left: 15px;
            margin-bottom: 15px;
        }
        .finding {
            background-color: #e8f4ea;
            border-left: 4px solid #28a745;
            padding: 10px 15px;
            margin: 10px 0;
            border-radius: 0 5px 5px 0;
        }
        .article {
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 15px;
            margin: 15px 0;
            background-color: #fafafa;
        }
        .article-title {
            font-weight: bold;
            color: #1E3A5F;
            margin-bottom: 8px;
        }
        .article-meta {
            font-size: 13px;
            color: #666;
        }
        .high-impact {
            display: inline-block;
            background-color: #FFD700;
            color: #333;
            padding: 2px 8px;
            border-radius: 4px;
            font-size: 11px;
            font-weight: bold;
            margin-left: 10px;
        }
        .trend-tag {
            display: inline-block;
            background-color: #e3f2fd;
            color: #1565c0;
            padding: 3px 10px;
            border-radius: 15px;
            font-size: 12px;
            margin: 3px;
        }
        .idea {
            background-color: #fff3e0;
            border-left: 4px solid #ff9800;
            padding: 15px;
            margin: 15px 0;
            border-radius: 0 5px 5px 0;
        }
        .idea-type {
            font-weight: bold;
            color: #e65100;
            margin-bottom: 5px;
        }
        .pico-box {
            background-color: #f0f7ff;
            border: 1px solid #b3d4fc;
            border-radius: 8px;
            padding: 12px;
            margin: 10px 0;
        }
        .pico-title {
            font-weight: bold;
            color: #1565c0;
            margin-bottom: 8px;
            font-size: 14px;
        }
        .pico-item {
            margin: 6px 0;
            font-size: 13px;
            line-height: 1.5;
        }
        .pico-label {
            display: inline-block;
            background-color: #1565c0;
            color: white;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: bold;
            font-size: 11px;
            margin-right: 8px;
            min-width: 80px;
            text-align: center;
        }
        .chinese-summary {
            background-color: #fff8e1;
            border-left: 4px solid #ffc107;
            padding: 12px 15px;
            margin: 10px 0;
            border-radius: 0 8px 8px 0;
            font-size: 13px;
            line-height: 1.8;
        }
        .chinese-summary-title {
            font-weight: bold;
            color: #f57c00;
            margin-bottom: 8px;
        }
        .summary-section {
            margin: 8px 0;
        }
        .summary-label {
            color: #e65100;
            font-weight: bold;
        }
        .footer {
            text-align: center;
            margin-top: 30px;
            padding-top: 20px;
            border-top: 1px solid #e0e0e0;
            color: #666;
            font-size: 12px;
        }
        a {
            color: #1565c0;
            text-decoration: none;
        }
        a:hover {
            text-decoration: underline;
        }
        @media (max-width: 600px) {
            .metrics {
                flex-direction: column;
            }
            .metric {
                margin: 10px 0;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">
            <h1>腎臟學研究週報</h1>
            <p>2026年02月09日 | 自動追蹤最新高品質腎臟學臨床研究</p>
        </div>

        <!-- 關鍵指標 -->
        <div class="metrics">
            <div class="metric">
                <div class="metric-value">11</div>
                <div class="metric-label">總文章數</div>
            </div>
            <div class="metric">
                <div class="metric-value">2</div>
                <div class="metric-label">高影響力期刊</div>
            </div>
            <div class="metric">
                <div class="metric-value">2</div>
                <div class="metric-label">兒童腎臟學</div>
            </div>
            <div class="metric">
                <div class="metric-value">9</div>
                <div class="metric-label">成人腎臟學</div>
            </div>
        </div>

        <!-- 主要發現 -->
        <div class="section">
            <h2>本週重點發現</h2>
            <div class="finding">本週熱門研究主題: biomarker (3篇), mortality (3篇), cardiovascular (2篇)</div>
            <div class="finding">高影響力期刊發表 2 篇，包括: BMC pediatrics, Lancet (London, England)</div>
            <div class="finding">高品質證據: 2 篇 RCT, 0 篇統合分析</div>

        </div>

        <!-- 熱門研究主題 -->
        <div class="section">
            <h2>熱門研究主題</h2>
            <div>
                <span class="trend-tag">biomarker (3)</span>
                <span class="trend-tag">mortality (3)</span>
                <span class="trend-tag">cardiovascular (2)</span>
                <span class="trend-tag">heart failure (2)</span>
                <span class="trend-tag">inflammation (1)</span>
                <span class="trend-tag">fibrosis (1)</span>
                <span class="trend-tag">personalized (1)</span>
                <span class="trend-tag">quality of life (1)</span>
                <span class="trend-tag">proteinuria (1)</span>
                <span class="trend-tag">SGLT2 inhibitor (1)</span>

            </div>
        </div>

        <!-- 重點文章 -->
        <div class="section">
            <h2>重點文章</h2>

            <div class="article">
                <div class="article-title">
                    TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198.<span class="high-impact">高影響力期刊</span>
                </div>
                <div class="article-meta">
                    Lancet (London, England) | 隨機對照試驗 | 2026 Feb 07
                    <br><a href="https://pubmed.ncbi.nlm.nih.gov/41616795/" target="_blank">在 PubMed 查看</a>
                </div>
                <div class="pico-box"><div class="pico-title">PICO 格式分析</div><div class="pico-item"><span class="pico-label">P 族群</span>proteinuria response (≥25% UPCR reduction from baseline) at week 12</div><div class="pico-item"><span class="pico-label">I 介入</span>receive placebo or BI 764198 at doses of 20 mg</div><div class="pico-item"><span class="pico-label">C 對照</span>placebo over 12 weeks in participants aged 18-75 years with biopsy-confirmed primary FSGS (based on the absence of clinical evidence of secondary cause) or with a disease-causing TRPC6 variant</div><div class="pico-item"><span class="pico-label">O 結果</span>the proportion of participants with proteinuria response (≥25% UPCR reduction from baseline) at week 12</div></div>
                
                <div class="chinese-summary">
                    <div class="chinese-summary-title">中文摘要整理</div>
                    <div class="summary-section"><span class='summary-label'>研究背景</span> In focal segmental glomerulosclerosis (FSGS), transient receptor potential cation channel, subfamily C, member 6 (TRPC6) overactivity might cause podocyte loss and progressive kidney function decline.</div><div class='summary-section'><span class='summary-label'>研究方法</span> This multicentre phase 2, double-blind, placebo-controlled, randomised controlled trial assessed BI 764198 (20 mg, 40 mg, or 80 mg once daily) versus placebo over 12 weeks in participants aged 18-75 years with biopsy-confirmed primary FSGS (based on the absence of clinical evidence of secondary caus...</div><div class='summary-section'><span class='summary-label'>主要結果</span> From March 10, 2022, to Sept 3, 2024, 139 participants were screened and 67 were randomly assigned to receive placebo or BI 764198 at doses of 20 mg, 40 mg, or 80 mg (five participants were randomly assigned in error and were not treated).</div><div class='summary-section'><span class='summary-label'>結論</span> BI 764198 lowered proteinuria and was well tolerated by participants in this trial. This is the first evidence of efficacy with a podocyte-targeted therapy in FSGS.</div>
                </div>
            </div>

            <div class="article">
                <div class="article-title">
                    Role of renal doppler in children with idiopathic nephrotic syndrome.<span class="high-impact">高影響力期刊</span>
                </div>
                <div class="article-meta">
                    BMC pediatrics | 研究 | 2026 Feb 03
                    <br><a href="https://pubmed.ncbi.nlm.nih.gov/41634692/" target="_blank">在 PubMed 查看</a>
                </div>
                <div class="pico-box"><div class="pico-title">PICO 格式分析</div><div class="pico-item"><span class="pico-label">P 族群</span>idiopathic nephrotic syndrome</div><div class="pico-item"><span class="pico-label">O 結果</span>at diagnosis</div></div>
                
                <div class="chinese-summary">
                    <div class="chinese-summary-title">中文摘要整理</div>
                    <div class="summary-section"><span class='summary-label'>研究目的</span> 本世代研究旨在探討ed to measure serial renal resistive index (RI) in pediatric patients with idiopathic nephrotic syndrome to assess its predictive value for steroid resistance and disease outcome.</div><div class='summary-section'><span class='summary-label'>研究方法</span> This prospective cohort study included 60 patients with idiopathic nephrotic syndrome aged 5 to < 18 years. Renal Doppler was performed on all children, and renal RI was measured at diagnosis, after 1, 3, and 6 months of diagnosis.</div><div class='summary-section'><span class='summary-label'>主要結果</span> The average interlobar renal RI of the right and left kidneys at diagnosis, during follow-up at 1, 3, and 6 months, was significantly higher in steroid-resistant nephrotic syndrome than in the steroid-sensitive nephrotic syndrome.</div><div class='summary-section'><span class='summary-label'>結論</span> Renal RI might be an effective non-invasive tool for early prediction and risk stratification of steroid resistance in pediatric patients with idiopathic nephrotic syndrome. Its utility lies in supporting earlier clinical decisions rather than replacing established diagnostic methods.</div>
                </div>
            </div>

            <div class="article">
                <div class="article-title">
                    Renal function trajectories in 'De Novo' heart failure with reduced ejection fraction: impact on outcomes.
                </div>
                <div class="article-meta">
                    Open heart | 研究 | 2026 Feb 06
                    <br><a href="https://pubmed.ncbi.nlm.nih.gov/41651561/" target="_blank">在 PubMed 查看</a>
                </div>
                <div class="pico-box"><div class="pico-title">PICO 格式分析</div><div class="pico-item"><span class="pico-label">P 族群</span>stable or improved eGFR had lower total mortality and HF readmission rates</div><div class="pico-item"><span class="pico-label">I 介入</span>strategies to mitigate renal function decline and improve patient care</div><div class="pico-item"><span class="pico-label">O 結果</span>using the CKD-Epidemiology Collaboration formula</div></div>
                
                <div class="chinese-summary">
                    <div class="chinese-summary-title">中文摘要整理</div>
                    <div class="summary-section"><span class='summary-label'>研究目的</span> 本世代研究旨在探討Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate renal function trajectories and their impact on major clinical outcomes in a cohort of patients hospitalised for 'de novo' HF with reduced ejection fraction (HFrEF).</div><div class='summary-section'><span class='summary-label'>研究方法</span> This is a prospective cohort study that included patients hospitalised for 'de novo' HFrEF at two university hospitals. Renal function was assessed using the CKD-Epidemiology Collaboration formula. Total mortality and the combined total mortality and HF readmissions were evaluated during follow-up.</div><div class='summary-section'><span class='summary-label'>主要結果</span> Of 370 patients, 306 were eligible. At discharge, 24.6% had estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m2. Higher eGFR at discharge was associated with better outcomes. During follow-up, 79.1% showed eGFR ≥45 mL/min/1.73 m2.</div><div class='summary-section'><span class='summary-label'>結論</span> In patients with 'de novo' HFrEF, renal function deterioration at discharge correlated with poorer outcomes. However, stabilisation or improvement during follow-up was linked to better prognosis.</div>
                </div>
            </div>

            <div class="article">
                <div class="article-title">
                    Sex Associated Biomarker Differences in Chronic Kidney Disease Progression and Mortality.
                </div>
                <div class="article-meta">
                    Clinical journal of the American Society of Nephrology : CJASN | 研究 | 2026 Feb 05
                    <br><a href="https://pubmed.ncbi.nlm.nih.gov/41642662/" target="_blank">在 PubMed 查看</a>
                </div>
                <div class="pico-box"><div class="pico-title">PICO 格式分析</div><div class="pico-item"><span class="pico-label">P 族群</span>non-dialysis-dependent CKD and 84 controls from NURTuRE-CKD</div><div class="pico-item"><span class="pico-label">I 介入</span>factors</div><div class="pico-item"><span class="pico-label">O 結果</span>outcomes</div></div>
                
                <div class="chinese-summary">
                    <div class="chinese-summary-title">中文摘要整理</div>
                    <div class="summary-section"><span class='summary-label'>研究背景</span> Males with chronic kidney disease (CKD) experience worse outcomes than females, a difference not fully explain ed by comorbidities or sociocultural factors. We explored whether sex-based differences in biomarkers could account for this difference in risk.</div><div class='summary-section'><span class='summary-label'>研究方法</span> Our study included 1,680 male and 1,204 female participants with non-dialysis-dependent CKD and 84 controls from NURTuRE-CKD, a prospective multicentre cohort study. Twenty-one biomarkers relating to kidney injury and fibrosis, inflammation, and cardiovascular stress were measured.</div><div class='summary-section'><span class='summary-label'>主要結果</span> Sex differences in biomarker concentrations were observed in both controls and CKD participants. In male controls, higher levels of urinary Vascular Endothelial Growth Factor, Tissue Inhibitor of Metalloproteinases-1 and blood Neutrophil Gelatinase-Associated Lipocalin, soluble Cluster of Differenti...</div><div class='summary-section'><span class='summary-label'>結論</span> Male sex was associated with a higher risk of kidney failure and mortality, despite adjustment for demographic, clinical, and treatment factors. Males had higher levels of inflammatory and extracellular matrix deposition biomarkers.</div>
                </div>
            </div>

            <div class="article">
                <div class="article-title">
                    Associations between the triglyceride glucose-body roundness index and frailty trajectory in populations with cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study.
                </div>
                <div class="article-meta">
                    The journals of gerontology. Series A, Biological sciences and medical sciences | 研究 | 2026 Feb 05
                    <br><a href="https://pubmed.ncbi.nlm.nih.gov/41389335/" target="_blank">在 PubMed 查看</a>
                </div>
                <div class="pico-box"><div class="pico-title">PICO 格式分析</div><div class="pico-item"><span class="pico-label">P 族群</span>cardiovascular-kidney-metabolic (CKM) syndrome</div><div class="pico-item"><span class="pico-label">I 介入</span>target for older adults with cardiovascular-kidney-metabolic (CKM) syndrome</div></div>
                
                <div class="chinese-summary">
                    <div class="chinese-summary-title">中文摘要整理</div>
                    <div class="summary-section"><span class='summary-label'>研究背景</span> Frailty is a key intervention target for older adults with cardiovascular-kidney-metabolic (CKM) syndrome. Evidence suggests that the triglyceride glucose (TyG) index and body roundness index (BRI) are associated with frailty; however, the predictive value of their combination (TyG-BRI) remains uncl...</div><div class='summary-section'><span class='summary-label'>研究方法</span> We analyzed data from 3687 middle-aged and older adults with CKM syndrome in the China Health and Retirement Longitudinal Study (CHARLS, 2011-2020). The frailty index serving as the outcome variable was constructed based on 30 multidimensional health deficit items.</div><div class='summary-section'><span class='summary-label'>主要結果</span> Three distinct frailty trajectories emerged: pre-frailty to frailty deterioration (18.8%), persistent frailty (53.7%), and pre-frailty transition to health (27.4%).</div><div class='summary-section'><span class='summary-label'>結論</span> The TyG-BRI may be an early metabolic biomarker for pre-frailty to frailty deterioration in individuals with CKM syndrome, particularly in older adults. These findings suggest a critical intervention window targeting metabolic dysregulation during the pre-frailty stage.</div>
                </div>
            </div>

        </div>

        <!-- 研究想法 -->
        <div class="section">
            <h2>研究想法建議</h2>

            <div class="idea">
                <div class="idea-type">[熱門主題延伸] biomarker</div>
                <p>目前 'biomarker' 是研究熱點 (3 篇相關文章)，可考慮：<br>1. 在本地族群中驗證相關發現<br>2. 結合其他熱門主題進行交叉研究<br>3. 針對特定亞群進行深入分析</p>
                <p><strong>建議研究類型:</strong> 觀察性研究 / 回顧性分析</p>
            </div>

            <div class="idea">
                <div class="idea-type">[熱門主題延伸] mortality</div>
                <p>目前 'mortality' 是研究熱點 (3 篇相關文章)，可考慮：<br>1. 在本地族群中驗證相關發現<br>2. 結合其他熱門主題進行交叉研究<br>3. 針對特定亞群進行深入分析</p>
                <p><strong>建議研究類型:</strong> 觀察性研究 / 回顧性分析</p>
            </div>

            <div class="idea">
                <div class="idea-type">[熱門主題延伸] cardiovascular</div>
                <p>目前 'cardiovascular' 是研究熱點 (2 篇相關文章)，可考慮：<br>1. 在本地族群中驗證相關發現<br>2. 結合其他熱門主題進行交叉研究<br>3. 針對特定亞群進行深入分析</p>
                <p><strong>建議研究類型:</strong> 觀察性研究 / 回顧性分析</p>
            </div>

        </div>

        <!-- 頁尾 -->
        <div class="footer">
            <p>此報告由 PubMed 腎臟學研究週報系統自動生成</p>
            <p>報告時間: 2026年02月09日</p>
        </div>
    </div>
</body>
</html>
